14
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T40377 | Nicotredole | Tryptamide | Others |
Nicotredole (Tryptamide) (Tryptamide) is an orally active analgesic and anti-inflammatory agent. Nicotredole exhibits evident anti-inflammatory effects of potency comparable with Phenylbutazone. Nicotredole has only weak... | |||
T4503 | Talniflumate | Somalgen | Chloride channel , COX , N-Acetylglucosaminyltransferase , Anion Exchanger |
Talniflumate (Somalgen) is a calcium-activated chloride channel (hCLCA1/mCLCA3) blocker that reduces mucin synthesis and releases in animal models and cell culture. It possesses anti-inflammatory actions via inhibition o... | |||
T3S0509 | Gaultherin | COX | |
Gaultherin has analgesic, and anti-inflammatory activities.Gaultherin lacks gastric ulcerogenic effect, because of it released salicylate in intestine slowly, not in stomach and it left the cyclooxygenase-1 unaffected, w... | |||
T24090 | Glaziovine | ||
Glaziovine is an agent of anti-ulcerogenic natural alkaloid. | |||
TN5030 | Sitoindoside I | Antifection | |
Sitoindoside I has anti-ulcerogenic activity. | |||
TN1642 | Ferruginol | BCL , PARP , Caspase | |
Ferruginol has anti-plasmodial, leishmanicidal, anti-ulcerogenic, cardioprotective, anticancer, anti-oxidative and anti-inflammatory activities, it can induce apoptosis in non-small cell lung cancer (NSCLC) cells. | |||
T64063 | COX-2-IN-24 | ||
COX-2-IN-24 is an orally active COX-2 inhibitor (IC50: 0.17 μM) with anti-inflammatory and hypo-ulcerogenic effects. | |||
T63348 | COX-2-IN-23 | ||
COX-2-IN-23 is a selective inhibitor of COX-2, with IC50 values of 0.28 and 20.14 μM for COX-2 and COX-1, respectively.COX-2-IN-23 exhibits anti-inflammatory effects as well as low ulcerogenic effects. | |||
T83599 | (+)-Leucocyanidin | 2,3-trans-3,4-trans-Leucocyanidin,(2R,3S,4R)-Leucocyanidin,3,4-trans-Leucocyanidin | |
(+)-Leucocyanidin, an isoform of leucocyanidin and potent anti-ulcerogenic agent, has been extracted from Litchi chinensis. This compound exhibits considerable protective properties in rat models against aspirin-induced ... | |||
T60978 | COX-2-IN-7 | ||
COX-2-IN-7 (compound 4a) is a potent, selective, and orally active COX-2 inhibitor which is higher selectivity than Celecoxib with an IC 50 value of 6.585 uM. COX-2-IN-7 has good anti-inflammatory and low ulcerogenic act... | |||
T63104 | INOS/PGE2-IN-1 | ||
iNOS/PGE2-IN-1 is an iNOS/PGE2 inhibitor and a potent anti-inflammatory agent. iNOS/PGE2-IN-1 exhibits an inhibitory effect on LPS-induced NO production and has a low ulcerogenic potential. | |||
T27968 | M-5011 | T-3788,S-MTPPA,M 5011,M-5011C | |
M-5011 is a non-steroidal anti-inflammatory drug and immunomodulator potentially for the treatment of inflammation and pain. M-5011 had an effective antinociceptive activity (ED50 value) of 0.63 mg/kg. M-5011 partially i... | |||
T63646 | COX-2-IN-9 | ||
COX-2-IN-9 is a selective, potent, orally active COX-2 inhibitor (IC50: 10.17 μM).COX-2-IN-9 has a higher COX-2 selectivity than Celecoxib.COX-2-IN-9 exhibits good in vivo anti-inflammatory activity and low ulcerogenic e... | |||
T78705 | COX-2-IN-30 | COX | |
COX-2-IN-30, a benzenesulfonamide derivative, is an orally active, dual inhibitor of cyclooxygenase-2 (COX-2; IC50 = 49 nM) and cyclooxygenase-1 (COX-1; IC50 = 10.4 μM), as well as 5-lipoxygenase (5-LOX; IC50 = 2.4 μM). ... |